510(k) Report

510(k) · Cleared

Recalled · Class II · 2022

Piston Syringe

K944941510(k) TraditionalCleared Dec 5, 199459-day reviewClass I21 CFR 868.1100Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Martell Medical Products, Inc. · CBT Arterial Blood Sampling Kit

Cleared on Dec 5, 1994 after a 59-day review. FDA lists a 510(k) statement for it but has not posted the file, so its predicates are not known. It has been recalled once.

Decided
Dec 5, 1994
Review
59 days
Class
Class I
Product code
CBT
Recalls
1
Predicates
0

FDA lists a 510(k) statement for it but has not posted the file, so its predicates are not known.

FIG. 1 — Lineage of K944941Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CBT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against?

FDA lists a 510(k) statement for it but has not posted the file, so its predicates are not known.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Sep 8, 2022Class IIZ-1779-2022Process controlThe kits are being recalled due to a lack of sterility of a spare needle contained within the kits. There is a potential for skin infection or sepsis if the patient is exposed to a non-sterilized, unused needle.

No ancestor or descendant has a Class I recall.

How does its category compare?

All CBT devices

CBT Arterial Blood Sampling Kit: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CBT

2in 2007

2007: 2
2007high 2 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CBT

Too few CBT 510(k)s in any year since 2007 to give a median.

Recalls per year · CBT

14in 2011

2007: 22011: 142026 (partial year): 2
2007high 14 (2011) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CBT

20in 2025

2007: 52008: 102009: 72010: 202011: 62012: 142013: 132014: 62015: 102016: 302017: 222018: 152019: 192020: 102021: 242022: 132023: 132024: 252025: 20
2007high 30 (2016) · low 5 (2007)2025

MAUDE reports naming product code CBT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—25
20080—010
20090—07
20100—020
20110—146
20120—014
20130—013
20140—06
20150—010
20160—030
20170—022
20180—015
20190—019
20200—010
20210—024
20220—013
20230—013
20240—025
20250—020
20260—2—
Cite this page

510(k) Report. “K944941: Piston Syringe.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K944941

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026